Equity markets plunge over 1,000 points as fears of US tariffs spark widespread selling, intensifying selloff across sectors.

In addition, he will lean on Fidelity's U.S. real estate securities research team led by Steve Buller, as well as the firm's nearly 200 U.S. and international-equity research analysts, to provide ...

The trends on Gift Nifty indicate a flat-to-positive start for the Indian benchmark index. The Gift Nifty was trading around ...

Ripple's XRP saw a 3% gain on Monday as Bloomberg analysts Eric Balchunas and James Seyffart released a list of the most ...

Moat stocks thrived in January, dodging AI-driven tech turmoil with gains in health care and mid-cap standouts. Click to read ...

After technology companies rushed to adopt DeepSeek's artificial intelligence (AI) models, businesses in other industries ...

Likewise, Solana and XRP ETFs also got approval odds of 70% and 65%, respectively. Notably, only the Litecoin and Solana ETF ...

JMP Securities adjusted its price target for Esperion Therapeutics (NASDAQ:ESPR) shares, lowering it to $4.00 from the previous $7.00. Currently trading at $1.86, the stock sits well below analyst ...

According to industry sources, the market regulator is are working to ease a few of the guidelines issued in January. Sebi ...

In the sometimes-formulaic world of securities class action litigation, there’s a buzzy new reason for shareholders to sue: "AI washing." ...

Private consumption will be a key growth driver in 2025, where gross domestic product (GDP) is forecast to grow by 4.5% to ...